Probe into FDA's 'fast track' program
Sen. Sherrod Brown (D-OH) has asked the Congressional Research Service for information on the FDA's Fast Track designation for some drugs seeking NDA approval to see if it would make sense to eliminate the process.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.